01 Growing shift from live probiotics to stable, non-viable bioactive compounds The market is witnessing a clear shift from live probiotics toward stable, non-viable bioactive compounds, driven by concerns around product stability and safety. Unlike probiotics, postbiotics do not require strict storage conditions, making them more suitable for mass production and global distribution.This transition is also supported by growing scientific evidence highlighting the consistent efficacy of postbiotics in gut health, immunity, and metabolic support. Manufacturers increasingly favor postbiotics for their longer shelf life, formulation flexibility, and ease of incorporation into functional foods, supplements, and clinical nutrition products.
02 Ongoing R&D focusing on standardization and efficacy validation Research and development efforts in the global postbiotics market are increasingly centered on establishing standardized production processes and consistent quality benchmarks. Companies and research institutions are investing in controlled fermentation methods and precise characterization of bioactive components to ensure uniformity, safety, and reproducibility across postbiotic formulations.Efficacy validation has become a key priority, with expanded clinical studies aimed at proving functional benefits across digestion, immunity, and inflammation management. This scientific validation is strengthening regulatory confidence and supporting wider adoption of postbiotics in pharmaceuticals, medical nutrition, and functional food applications.
March 2026 ADM expanded its health and nutrition ingredient portfolio with advanced postbiotic solutions designed for functional foods, beverages, and dietary supplements supporting gut health and wellness applications.
January 2026 Chr. Hansen expanded its microbial health solutions portfolio with postbiotic ingredient innovations designed to support digestive health, immune function, and next-generation nutrition products.
October 2025 Kerry Group expanded its functional nutrition portfolio with advanced postbiotic ingredients and formulation solutions designed for food, beverage, and supplement manufacturers.
August 2025 Lallemand Health Solutions expanded its microbiome-focused ingredient portfolio with new postbiotic solutions supporting digestive wellness, immunity, and personalized nutrition applications.